Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/bain-goes-big-again-leading-350m-round-fund-oral-challenger-blockbuster-asthma-biologics
https://www.businesswire.com/news/home/20210114005054/en/Knopp-Biosciences-Announces-Positive-Top-Line-Results-from-the-Phase-2-EXHALE-Trial-of-Oral-Dexpramipexole-in-Moderate-to-Severe-Eosinophilic-Asthma
https://www.businesswire.com/news/home/20210517005253/en/Knopp-Biosciences-Reports-Positive-Results-From-the-Phase-2-EXHALE-Trial-of-Oral-Dexpramipexole-in-Moderate-to-Severe-Eosinophilic-Asthma-at-ATS-2021
https://www.fiercebiotech.com/biotech/knopp-s-oral-asthma-drug-hits-primary-endpoint-phase-2